AVEO Pharmaceuticals (AVEO)
Add to Watchlists Create an Alert
2.71
+0.01 +0.37%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
AVEO Pharmaceuticals Return on Equity:
-76.11% for March 31, 2013AVEO Pharmaceuticals Historical Return on Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -76.11% |
| Dec. 31, 2012 | -68.14% |
| Sept. 30, 2012 | -61.07% |
| June 30, 2012 | -50.97% |
| March 31, 2012 | -40.37% |
| Dec. 31, 2011 | 15.82% |
| Sept. 30, 2011 | 29.61% |
| June 30, 2011 | 45.05% |
| March 31, 2011 | 60.02% |
| Dec. 31, 2010 | -2440% |
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
AVEO Return on Equity Benchmarks
| Companies | |
|---|---|
| Onyx Pharmaceuticals | -19.22% |
| Galena Biopharma | -288.6% |
| Sarepta Therapeutics | -324.9% |
AVEO Return on Equity Rankings
| Overall |
43rd percentile 4315 of 7600 |
| Sector |
39th percentile 397 of 653 in Healthcare |
| Industry |
55th percentile 106 of 238 in Biotechnology |
AVEO Return on Equity Range, Past 5 Years
| Minimum | -2440% | Dec 2010 |
| Maximum | 60.02% | Mar 2011 |
| Average | -258.7% |
